Hepatitis C virus and human T-lymphotropic virus coinfection: Epidemiological, clinical, laboratory and histopathological features

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 42, Issue 4, 2009, Pages 363-368

  Milagres, Flávio Augusto Pádua ^a   Duarte, Maria Irma Seixas ^a   Viso, Ana Teresa ^a   Segurado, Aluisio Cotrim ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Discriminant analysis; Epidemiological studies; Hepatitis C virus; Human T lymphotropic virus type 1; Human T lymphotropic virus type 2

Indexed keywords

AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ABDOMINAL PAIN; ADULT; ALCOHOL CONSUMPTION; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN TISSUE; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; SEXUALITY; THROMBOCYTE COUNT; VIRUS INFECTION;

ADULT; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; LIVER; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

HEPATITIS C VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 70349925662     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822009000400001     Document Type: Article

References (38)

1. Agresti A. Categorical data analysis. Wiley, New York, 1990.
2. Anderson BJ, Gogineni A, Charuvastra A, Longabaugh R, Stein MD. Adverse drinking consequences among alcohol abusing intravenous drug users. Alcoholism, Clinical and Experimental Research 25:41-45, 2001. (Pubitemid 32147692)
3. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293, 1996.
4. Boschi-Pinto C, Stuver S, Okayama A, Trichopoulos D, Orav EJ, Tsubouchi H, Mueller N. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with HTLV-I in Miyazaki, Japan. The Journal of Infectious Diseases 181:35-41, 2000. (Pubitemid 30049030)
5. Carneiro-Proietti AB, Lima-Martins MV, Passos VM, Carmo RA, Pinheiro SR, Rocha PR, Proietti FA, Ferreira PC, Rocha VG. Presence of human immunodeficiency virus (HIV) and T-lymphotropic virus type I and II (HTLV-I/II) in a haemophiliac population in Belo Horizonte, Brazil, and correlation with additional serological results. Haemophilia 4:47-50, 1998.
6. Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Annals of Internal Medicine 118:448-454, 1993.
7. Chan YH. Discriminant analysis. Singapore Medical Journal 46:54-62, 2005.
8. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. Journal of Hepatology 39:239-244, 2003. (Pubitemid 36920560)
9. nd edition Wiley, New York, 1980.
10. Dong B, Xie YQ, Chen K, Wang T, Tang W, You WC, Li JY. Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions. World Journal of Gastroenterology 11:3595-3600, 2005. (Pubitemid 40903521)
11. Dourado I, Andrade T, Galvão-Castro B. HTLV-I in Northeast Brazil: differences for male and female injecting drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19:426-429, 1998. (Pubitemid 28536054)
12. Ferreira Jr OC, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hamerschlak N. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil. Transfusion 35:258-263, 1995.
13. Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jimenez V, Silva T, Project Itinere Working Group. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates. Journal of Clinical Virology 35:244-249, 2006. (Pubitemid 43188968)
14. Gabbai AA, Bordin JO, Vieira-Filho JP, Kuroda A, Oliveira AS, Cruz MV, Ribeiro AA, Delaney SR, Henrard DR, Rosario J. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. The American Journal of Tropical Medicine and Hygiene 49:664-671, 1993. (Pubitemid 2038875)
15. Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA. Lancet 336:878-879, 1990b. (Pubitemid 20311369)
16. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook, JA, Trute A, Parker D, Barbara JAJ, Contreras M, Aloysius S. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 335:1418-1422, 1990a.
17. Heneine W, Khabbaz RF, Lal RB, Kaplan JE. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals. Journal of Clinical Microbiology 30:1605-1607, 1992.
18. Innis MA, Gelfand DH, Sninsky JJ, White T. PCR-Protocols: a guide to methods and applications. Academic Press, New York, 1990.
19. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, Macsween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmidt M, Thaler H. Histological grading and staging of chronic hepatitis. Journal of Hepatology 22:696-699, 1995.
20. th edition. Prentice Hall, New Jersey, 1998.
21. Koblin BA, Factor SH, Wu Y, Vlahov D. Hepatitis C virus infection among noninjecting drug users in New York City. Journal of Medical Virology 70:387-390, 2003. (Pubitemid 36638051)
22. Lang CA, Conrad S, Garrett L, Battistutta D, Cooksley WG, Dunne MP, Macdonald GA. Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. Journal of Pain and Symptom Management 31:335-344, 2006.
23. Ministério da Saúde. Guia de manejo clínico do HTLV. Normas e Manuais Técnicos-Série Manuais; no 3-CN-DST e Aids: Brasília, 2003.
24. Morimoto HK, Caterino-De-Araujo A, Morimoto AA, Reiche EM, Ueda LT, Matsuo T, Stegmann JW, Reiche FV. Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Parana, Brazil. AIDS Research and Human Retroviruses 21:256-262, 2005.
25. Murphy EL, Glynn S, Watanabe K, Fridey J, Smith J, Sacher R, Wright D, Schreiber G, Luban N. Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study Investigators. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 17:332-338,1998.
26. Nakashima K, Ikematsu H, Hayashi J, Kishihara Y, Mutsutake A, Kashiwagi S. Intrafamilial transmission of hepatitis-C virus among the population of an endemic area of Japan. The Journal of The American Medical Association 274:1459-1461, 1995.
27. Okayama A, Maruyama T, Tachibana N, Hayashi K, Kitamura T, Mueller N, Tsubouchi H. Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus. Japanese Journal of Cancer Research 86:1-4, 1995.
28. Pando MA, Bautista CT, Maulen S, Duranti R, Marone R, Rey J, Vignoles M, Eirin ME, Biglione MM, Griemberg G, Montano SM, Carr JK, Sanchez JL, Avila MM. Epidemiology of Human Immunodeficiency Virus, Viral Hepatitis (B and C), Treponema pallidum, and Human T-Cell Lymphotropic I/II Virus Among Men Who Have Sex With Men in Buenos Aires, Argentina. Sexually Transmitted Diseases 33:307-313, 2006. (Pubitemid 43964600)
29. Porto AF, Santos SB, Alcantara L, Guerreiro JB, Passos J, Gonzalez T, Neva F, Gonzalez D, Ho JL, Carvalho EM. HTLV-1 modifies the clinical and immunological response to schistosomiasis. Clinical and Experimental Immunology 137:424-429, 2004. (Pubitemid 39013091)
30. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL; HTLV Outcomes Study Investigators. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. The Journal of Infectious Diseases 191:1490-1497, 2005.
31. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC, Trent Hepatitis C Study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 53:451-455, 2004.
32. Salles NA, Sabino EC, Barreto CC, Barreto AM, Otani MM, Chamone DF. The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil. Revista Panamericana de Salud Pública 13:111-116, 2003.
33. Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. The American Journal of Tropical Medicine and Hygiene 57:142-148, 1997.
34. Segurado AC, Braga P, Etzel A, Cardoso MR. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care and STDs 18:135-143, 2004.
35. Stuver SO, Tachibana N, Okayama A, Shioiri S, Tsunetoshi Y, Tsuda K, Mueller NE. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. The Journal of Infectious Diseases 167:57-65, 1993. (Pubitemid 23002837)
36. Telzak EE, Hershow R, Kalish LA, Hardy Jr WD, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 19:513-518, 1998. (Pubitemid 128704083)
37. Tuke PW, Luton P, Garson JA. Diferential diagnosis of HTLV-I and HTLV-II infection by restriction enzyme analysis of "nested" PCR products. Journal of Virological Methods 40:163-174, 1992.
38. Vitek CR, Gracia FI, Giusti R, Fukuda K, Green DB, Castillo LC, Armien B, Khabbaz RF, Levine PH, Kaplan JE, et al. Evidence for sexual and mother-to-child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama. The Journal of Infectious Diseases 171:1022-1026, 1995.